Dr. Vincent Lam, M.D.
Claim this profileJohns Hopkins University
Studies Uterine Tumors
Studies Esophageal Cancer
5 reported clinical trials
10 drugs studied
Area of expertise
1Uterine Tumors
Stage IV
HER2 positive
Stage III
2Esophageal Cancer
Stage II
Stage III
HER2 positive
Affiliated Hospitals
Clinical Trials Vincent Lam, M.D. is currently running
Peptide Vaccine
for ALK+ Lung Cancer
The purpose of this study is to evaluate the safety of a cancer peptide vaccine to prevent or delay acquired resistance in advanced ALK+ lung cancer patients currently on ALK targeted therapy.
Recruiting1 award Phase 1 & 25 criteria
DF1001
for Solid Cancers
This trial is testing a new treatment called DF1001-001 that helps the immune system target and destroy cancer cells. It focuses on patients with certain types of cancers that have a protein called HER2. The treatment works by activating immune cells to recognize and attack these cancer cells.
Recruiting1 award Phase 1 & 252 criteria
More about Vincent Lam, M.D.
Clinical Trial Related1 year of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Vincent Lam, M.D. has experience with
- Nivolumab
- Relatlimab
- Prophylactic Peptide Vaccine
- Carboplatin
- Paclitaxel
- Radiation
Breakdown of trials Vincent Lam, M.D. has run
Esophageal Cancer
Stomach Cancer
Gastroesophageal Cancer
Immune Checkpoint Inhibition
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Vincent Lam, M.D. specialize in?
Vincent Lam, M.D. focuses on Uterine Tumors and Esophageal Cancer. In particular, much of their work with Uterine Tumors has involved Stage IV patients, or patients who are HER2 positive.
Is Vincent Lam, M.D. currently recruiting for clinical trials?
Yes, Vincent Lam, M.D. is currently recruiting for 3 clinical trials in Baltimore Maryland. If you're interested in participating, you should apply.
Are there any treatments that Vincent Lam, M.D. has studied deeply?
Yes, Vincent Lam, M.D. has studied treatments such as Nivolumab, Relatlimab, Prophylactic Peptide Vaccine.
What is the best way to schedule an appointment with Vincent Lam, M.D.?
Apply for one of the trials that Vincent Lam, M.D. is conducting.
What is the office address of Vincent Lam, M.D.?
The office of Vincent Lam, M.D. is located at: Johns Hopkins University, Baltimore, Maryland 21287 United States. This is the address for their practice at the Johns Hopkins University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.